Andrew Hirsch - 15 Feb 2024 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role
President & CEO, Director
Signature
/s/ Jolie M. Siegel, Attorney-in-Fact
Issuer symbol
CCCC
Transactions as of
15 Feb 2024
Net transactions value
-$51,824
Form type
4
Filing time
15 Feb 2024, 18:18:19 UTC
Previous filing
15 Feb 2024
Next filing
03 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCCC Common Stock Tax liability $51,824 -6,560 -3% $7.90 210,741 15 Feb 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person.